Shailesh Bondarde

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 102 citations · Full text

A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer

William J. Gradishar, Virginia Kaklamani, Tarini Prasad Sahoo et al. · European Journal of Cancer · 2012 · 84 citations

First-line Therapy, Breast Oncology, Medicine +6

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 55 citations

Antifibrotic Therapy, Fortis-m Trial, Medicine +9

Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study

Minish Jain, Smita Uday Gupte, Shekhar G. Patil et al. · Breast Cancer Research and Treatment · 2016 · 55 citations · Full text

Treatment of advanced non-small-cell lung cancer

Kumar Prabhash, Amish Vora, Sewanti Limaye et al. · Cancer Research Statistics and Treatment · 2021 · 45 citations · Full text

Preclinical Therapeutics, Surgical Oncology, Advanced Lung Disease +18